EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A probiotic–drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling

Junfei Yang, Zuer Feng, Shuxin Sun, Tianqi Pei, Yunfei Li, Beiyang Xue, Chuangxi Zhou, Qingling Song, Yun Zhang, Lei Wang

Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7704-7720

DOI: 10.1016/j.apsb.2026.07.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Junfei Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BerberineGut microbiotaInflammatory bowel diseaseIntestinal barrierMetal–phenolic networkMicrobial therapyOral deliveryTryptophan metabolism

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Henan Key Laboratory of Nanomedicine for Targeting Diagnosis and Treatment, Zhengzhou University, Zhengzhou 450001, China.
  • Pingyuan Laboratory, State Key Laboratory of Antiviral Drugs, Zhengzhou University, Zhengzhou 450001, China.

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Yang, J., Feng, Z., Sun, S., Pei, T., Li, Y., Xue, B., Zhou, C., Song, Q., Zhang, Y., & Wang, L. (2026). A probiotic–drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling. Acta Pharmaceutica Sinica B, 16(11), 7704-7720. https://doi.org/10.1016/j.apsb.2026.07.013

Vancouver

Yang J, Feng Z, Sun S, Pei T, Li Y, Xue B, et al. A probiotic–drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling. Acta Pharmaceutica Sinica B. 2026;16(11):7704-7720. doi:10.1016/j.apsb.2026.07.013

BibTeX
@article{Yang2026,
  author = {Yang, Junfei and Feng, Zuer and Sun, Shuxin and Pei, Tianqi and Li, Yunfei and Xue, Beiyang and Zhou, Chuangxi and Song, Qingling and Zhang, Yun and Wang, Lei},
  title = {A probiotic–drug cascade system for inflammatory bowel disease via tryptophan metabolism and gut microbiome remodeling},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {7704--7720},
  doi = {10.1016/j.apsb.2026.07.013}
}
Kostenlos starten →